Royalty Pharma plc Share Price & Technical Analysis
RPRX · $54.50 (+1.77%)
Healthcare / Biotechnology
$54.50
+1.77%
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabet…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
9% return in May, -3% avg return in past 3 year May month.
37% return in 2026, 1% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 8% | 11% | 5% | 4% | 9% | – | – | – | – | – | – | – | 37% |
| 25 | 24% | 8% | -8% | 5% | 1% | 9% | 2% | -2% | -2% | 5% | 7% | -4% | 45% |
| 24 | 1% | 6% | 0% | -9% | -1% | -3% | 6% | 2% | -2% | -5% | -1% | -4% | -8% |
| 23 | -2% | -8% | 1% | -2% | -7% | -7% | 2% | -5% | -10% | -1% | 1% | 4% | -34% |
| 22 | 0% | -2% | 0% | 9% | -3% | 2% | 4% | -4% | -4% | 5% | 4% | -10% | 1% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$29.85B
P/E ratio
27.28
52W high
$54.63
52W low
$32.15
Volume
30,53,760
Beta
0.40
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Royalty Pharma plc share price today?
- Royalty Pharma plc (RPRX) last traded around $54.50 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does RPRX have?
- StockPro currently tracks 1 active signal(s) for RPRX, including breakouts, momentum, and volume patterns. See the signals panel on this page.
- How can I analyze Royalty Pharma plc stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.